Accelerated reversal of atracurium blockade with divided doses of neostigmine

[1]  C. J. Jones,et al.  Antagonism of neuromuscular blockade , 1988, Anaesthesia.

[2]  R. Middaugh,et al.  Rapid Tracheal Intubation with Vecuronium , 1988 .

[3]  G. Absood,et al.  The optimal priming dose for atracurium , 1986, Canadian Anaesthetists' Society journal.

[4]  G. Absood,et al.  Rapid tracheal intubation with atracurium - a comparison of priming intervals , 1986, Canadian Anaesthetists' Society journal.

[5]  F. Donati,et al.  Accelerated onset of pancuronium with divided doses. , 1985, Canadian Anaesthetists' Society journal.

[6]  R. Miller.  The priming principle. , 1985, Anesthesiology.

[7]  M. Mehta,et al.  Facilitation of Rapid Endotracheal Intubations with Divided Doses of Nondepolarizing Neuromuscular Blocking Drugs , 1985, Anesthesiology.

[8]  F. Foldes,et al.  Rapid Tracheal Intubation with Vecuronium: The Priming Principle , 1984, Anesthesiology.

[9]  F. Donati,et al.  Accelerated onset of pancuronium with divided doses , 1985 .

[10]  J. Williams,et al.  Recovery characteristics following antagonism of atracurium with neostigmine or edrophonium. , 1984, British journal of anaesthesia.

[11]  O. Kemmotsu,et al.  Intubation conditions after atracurium and suxamethonium. , 1983, British journal of anaesthesia.

[12]  F. Foldes,et al.  Protein binding of atracurium and other short-acting neuromuscular blocking agents and their interaction with human cholinesterases. , 1983, British journal of anaesthesia.

[13]  H. H. Ali,et al.  Clinical Pharmacology of Atracurium Besylate (BW 33A): A New Non‐depolarizing Muscle Relaxant , 1982, Anesthesia and analgesia.

[14]  R. Cronnelly,et al.  Antagonism of neuromuscular blockade. , 1982, British journal of anaesthesia.

[15]  J. Viby-Mogensen,et al.  Clinical assessment of neuromuscular transmission. , 1982, British journal of anaesthesia.

[16]  R. Mirakhur,et al.  Antagonism of neuromuscular block. , 1982, British journal of anaesthesia.

[17]  D. Stanski,et al.  Pharmacokinetics of Edrophonium and Neostigmine When Antagonizing d‐Tubocurarine Neuromuscular Blockade in Man , 1981, Anesthesiology.

[18]  W. Bowman.  Prejunctional and Postjunctional Cholinoceptors at the Neuromusclar Junction , 1980, Anesthesia and analgesia.

[19]  J. P. Payne,et al.  Neuromuscular blockade by neostigmine in anaesthetized man. , 1980, British journal of anaesthesia.

[20]  K. Muir,et al.  THE RELATIONSHIP BETWEEN THE PHARMACOKINETICS, CHOLINESTERASE INHIBITION AND FACILITATION OF TWITCH TENSION OF THE QUATERNARY AMMONIUM ANTICHOLINESTERASE DRUGS, NEOSTIGMINE, PYRIDOSTIGMINE, EDROPHONIUM AND 3‐HYDROXYPHENYLTRIMETHYLAMMONIUM , 1979, British journal of pharmacology.

[21]  D. Bevan.  Reversal of pancuronium with edrophonium , 1979, Anaesthesia.

[22]  M. D. Miyamoto.  The actions of cholinergic drugs on motor nerve terminals. , 1977, Pharmacological reviews.

[23]  H. H. Ali,et al.  Evaluation of Recovery From Nondepolarizing Neuromuscular Block, Using a Digital Neuromuscular Transmission Analyzer: Preliminary Report , 1973, Anesthesia and analgesia.

[24]  R. Miller,et al.  Comparative antagonism of d-tubocurarine-, gallamine-, and pancuronium-induced neuromuscular blockades by neostigmine. , 1972, Anesthesiology.

[25]  W. Paton,et al.  The margin of safety of neuromuscular transmission , 1967, The Journal of physiology.

[26]  R. Kitz.  THE CHEMISTRY OF ANTICHOLINESTERASE ACTIVITY , 1964 .

[27]  EDWIN C. Webb.  The Enzymes , 1961, Nature.

[28]  W. Bowman,et al.  A comparison between the effects of edrophonium and choline in the skeletal muscles of the cat. , 1959, British journal of pharmacology and chemotherapy.